NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $39,420 | -12.6% | 387 | -13.4% | 0.00% | 0.0% |
Q2 2023 | $45,107 | +13.8% | 447 | +3.7% | 0.00% | 0.0% |
Q1 2023 | $39,649 | -5.0% | 431 | -6.3% | 0.00% | 0.0% |
Q4 2022 | $41,731 | -89.1% | 460 | -89.4% | 0.00% | -90.0% |
Q1 2022 | $382,000 | +28.6% | 4,356 | +28.1% | 0.02% | +33.3% |
Q4 2021 | $297,000 | +15.6% | 3,400 | +7.8% | 0.02% | 0.0% |
Q3 2021 | $257,000 | -92.5% | 3,154 | -91.5% | 0.02% | -97.5% |
Q3 2015 | $3,410,000 | -9.4% | 37,093 | -3.1% | 0.60% | +20.0% |
Q2 2015 | $3,763,000 | -8.3% | 38,267 | -8.1% | 0.50% | -8.3% |
Q1 2015 | $4,105,000 | +3.8% | 41,628 | -2.5% | 0.54% | -0.5% |
Q4 2014 | $3,955,000 | -5.6% | 42,687 | -4.1% | 0.55% | -6.5% |
Q3 2014 | $4,189,000 | +4.2% | 44,500 | +0.2% | 0.59% | +1.0% |
Q2 2014 | $4,020,000 | +7.6% | 44,405 | +1.1% | 0.58% | -2.2% |
Q1 2014 | $3,735,000 | +9.4% | 43,930 | +3.4% | 0.59% | -9.7% |
Q4 2013 | $3,414,000 | +7.1% | 42,470 | +2.2% | 0.66% | -1.9% |
Q3 2013 | $3,188,000 | – | 41,565 | – | 0.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANAGED ASSET PORTFOLIOS, LLC | 332,962 | $27,452,000 | 7.32% |
Mawer Investment Management Ltd. | 7,721,327 | $636,623,000 | 5.86% |
Martin Investment Management, LLC | 133,246 | $10,986,000 | 5.56% |
SCHARF INVESTMENTS, LLC | 1,330,175 | $109,673,000 | 5.48% |
Hansberger Growth Investors, LP | 46,663 | $3,847,000 | 5.19% |
Bain Capital Public Equity Management II, LLC | 440,233 | $36,297,000 | 4.25% |
First Fiduciary Investment Counsel, Inc. | 187,633 | $15,470,000 | 4.10% |
GARLAND CAPITAL MANAGEMENT INC | 53,555 | $4,416,000 | 4.02% |
Lowell Blake & Associates Inc. | 37,219 | $3,069,000 | 3.94% |
PRENTISS SMITH & CO INC | 68,027 | $5,609,000 | 3.89% |